A method of altering fatty acid and/or triacylglycerol production in plants and/or algae is provided. The method includes altering activity levels of alpha-carboxyltransferase (-CT), a catalytic subunit of acetyl-CoA carboxylase (ACCase) by modulating an expression of at least one carboxyltransferase interaction (CTI) gene encoding at least one CTI protein.

This document relates to using bidirectional, multi-enzymatic scaffolds to biosynthesize cannabinoids in recombinant hosts.

A fungal cell capable of producing high levels of fatty acids and fatty acid-derived products comprises at least one modification to the endogenous fatty acid metabolism.

A mutant acetyl-CoA carboxylase (ACC) protein, a nucleic acid encoding the mutant ACC protein, and use thereof are provided. Specifically, compared with a parent ACC protein, the mutant ACC protein has mutations at amino acids corresponding to amino acid 1,879 and/or amino acid 2,186 of SEQ ID NO: 1. An ACC-mutated plant shows high herbicide resistance, and thus the present disclosure has very promising application prospects in the cultivation of an herbicide-resistant plant.

Provided are synthetic organisms and methods for the conversion of ethane and related substrates into 3-hydroxypropionate and related products.

This document relates to using bidirectional, multi-enzymatic scaffolds to biosynthesize cannabinoids in recombinant hosts.

A yeast cell for the production of fatty acids and/or fatty acid-derived products is genetically modified for overexpression of one or more endogenous yeast genes selected from the group consisting of ADP-ribosylation factor-binding protein, phosphatidylinositol 4,5-bisphosphate 5-phosphatase INP54, NADP-dependent isocitrate dehydrogenase IDP3, mitochondrial phosphatidylglycerophosphatase GEP4, triglyceride lipase TGL1, long chain fatty acyl-CoA synthetase FAA3, lipid phosphate phosphatase LPP1, and variants of such endogenous yeast genes. The yeast cell produces higher amount of fatty acids and/or fatty acid-derived products compared to a yeast cell not overexpressing the one or more endogenous yeast genes.

Microorganisms are genetically engineered to continuously produce fatty acids, fatty alcohols, cultured protein, or any combination thereof by microbial fermentation, particularly by microbial fermentation of a gaseous substrate. The microorganisms are C1-fixing. The production of fatty acids, fatty alcohols, and cultured proteins can be improved. This can be improved through the expression of 3-hydroxyacyl-ACP:CoA transacylases.

Disclosed are a novel nuclear localization sequence (NLS) mutant and a method for improving biosynthetic efficiency using same, belonging to the field of bioengineering. According to the present disclosure, a novel NLS is screened out, and recombinant yeast with improved metabolite synthesis efficiency is constructed by applying the NLS obtained through screening, which provides key technical support for developing a high-yield, stable and cost-effective yeast biosynthesis platform, and facilitates the use of recombinant yeast as a cell factory for large-scale industrial biomanufacturing.